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Abstract 
Objective: Automatic quantification of perifoveal vessel densities in optical coherence tomography 
angiography (OCT-A) images face challenges such as variable intra- and inter-image signal to noise 
ratios, projection artefacts from outer vasculature layers, and motion artefacts. This study 
demonstrates the utility of deep neural networks for automatic quantification of foveal avascular 
zone (FAZ) parameters and perifoveal vessel density of OCT-A images in healthy and diabetic 
eyes.  
Methods: OCT-A images of the foveal region were acquired using three OCT-A systems: a 
1060nm Swept Source (SS)-OCT prototype, RTVue XR Avanti (Optovue Inc., Fremont, CA), and 
the ZEISS Angioplex (Carl Zeiss Meditec, Dublin, CA). Automated segmentation was then 
performed using a deep neural network. Four FAZ morphometric parameters (area, min/max 
diameter, and eccentricity) and perifoveal vessel density were used as outcome measures.  
Results: The accuracy, sensitivity and specificity of the DNN vessel segmentations were 
comparable across all three device platforms. No significant difference between the means of the 
measurements from automated and manual segmentations were found for any of the outcome 
measures on any system. The intraclass correlation coefficient (ICC) was also good (≥ 0.51) for all 
measurements. 
Conclusion: Automated deep learning vessel segmentation of OCT-A may be suitable for both 
commercial and research purposes for better quantification of the retinal circulation. 
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Introduction 
Diabetic retinopathy (DR) is the most prevalent retinal vascular disease worldwide, affecting a third 
of people with diabetes(1). It ranks as the fifth most common cause of world-wide blindness and of 
global moderate to severe vision impairment(2). The pathophysiology of DR involves damage to 
the inner retinal  microcirculation leading to the disruption of the blood retinal barrier and capillary 
bed closure (3,4). Studies have shown that retinal ischemia secondary to capillary non-perfusion 
occurs in the early stages of diabetic retinopathy and is associated with disease severity and 
progression (5). In addition, decreased macular capillary density and enlargement of the foveal 
avascular zone (6) showed correlation with visual acuity in DR patients (7,8). Therefore, 
quantitative assessment of vascular changes at the capillary level may result in early DR detection, 
better disease severity stratification and timely intervention before the onset of irreversible vision 
loss. 
For the past 50 years, fluorescein angiography (FA) has been the gold standard modality for 
assessing retinal vascular diseases allowing accurate detection of large and medium sized vessels 
(9). However, it requires injection of a toxic dye and capillary visibility by FA is affected by poor 
contrast from background choroidal fluorescence and light scattering in the retina.  This poor 
capillary visualization increases with retinal depth making FA less suitable for deep capillary plexus 
detection. (10). Optical coherence tomography angiography (OCT-A) is a depth-resolved, non-
invasive, and dye-free imaging modality that uses flow-based contrast to visualize the multi-layered 
retinal circulation. By utilizing a custom built OCT- A prototype, our group has shown that OCT-A 
images provide histology-like anatomical information about human retinal capillary networks (11–
13). Recently, several studies have shown favourable comparisons between OCT-A and FA 
imaging in normal subjects(14) and patients with retinal vascular disease including DR(15,16). 
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Early efforts aimed at OCT-A perifoveal vessel density quantification utilized manual 
vessel tracing methods(14), but the process can be labour intensive and subject to intra- and inter-
observer variability(17). Fully automated techniques are being explored, but face challenges such as 
variable intra- and inter-image signal to noise ratios, projection artefacts from outer layer 
vasculature onto deeper layers, incorrect layer segmentation and motion artefacts(18–20). OCT-A 
signal intensity thresholding has been the foundation of most automated segmentation efforts thus 
far and progress has been made in applying additional filters for more accurate results(21,22). 
Improvements in automated segmentation and quantification of OCT-A images of the retinal 
vasculature may aid in its wider spread adoption and potential applications. 
Our group has previously demonstrated a novel automated deep learning method to 
segment and quantify retinal images from our prototype OCT-A machine using deep neural 
networks (DNN)(19). In this study, we expand upon the application of the algorithm in several 
ways: We utilize larger fields of view that are more clinically useful (2x2mm and 3x3mm) and 
locations (centered on the FAZ) from the original 1x1mm (perifoveal) to retrain the DNN, validate 
the DNN for 2 commercial OCT-A systems, include OCT-A images from eyes with DR, and 
automatically quantify FAZ parameters. To our knowledge, this is the first paper to validate an 
automated retinal vessel segmentation of  OCT-A images with manual segmentation across multiple 
platforms. 
 
Methods 
The protocol for this study was approved by the human research ethics committees of Simon Fraser 
University, the University of British Columbia, and the North Shore Long Island Jewish Health 
System and conducted in compliance with the Declaration of Helsinki. Written informed consent 
was obtained from all subjects. Patient imaging using the commercial device was performed at 
Vitreous Retina Macula Consultants of New York from February 2015 to April 2016 and North 
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Shore Associates, North Vancouver, British Columbia from September 2016 to April 2017. Patient 
imaging using the prototype device was performed in the Advanced Retinal Imaging and Analysis 
Laboratory (ARIAL) at the Eye Care Centre in Vancouver, British Columbia from July 2014 to 
October 2016. Data analysis for this study was performed from February 2016, to August 2017. The 
subjects underwent a standard ophthalmic examination and their level of retinopathy was 
determined by the treating physician using the Early Treatment of Diabetic Retinopathy Study 
(ETDRS)(23) staging. 
 
Inclusion criteria 
Subjects classified as diabetic were diagnosed with DR according to the ETDRS criteria by an 
experienced retina specialist. Subjects that comprised the control group showed no evidence of 
retinal or ocular pathology on examination. All subjects were screened for clear ocular media, 
ability to fixate, and competence to provide informed consent prior to imaging. 
 
Optical coherence tomography instrumentation 
Three OCT-A systems were used in this study: one prototype and two commercially available 
machines. The clinical prototype OCT-A system used in this study was designed and built by the 
Biomedical Optics Research Group (BORG) at Simon Fraser University using a 1060 nm swept-
source (Axsun Inc, Billerica, MA) with a 100 kHz A-scan rate. The axial resolution was ∼6 μm in 
tissue and the estimated focal waist (1/e2 Gaussian radius) was ∼7.3 μm at the retina. The details of 
this acquisition system have previously been published(24). One commercial OCT-A system used 
in this report was the RTVue XR Avanti (Optovue Inc., Fremont, CA) which is an 840 nm spectral 
domain system with an A-scan rate of 70 kHz. The XR Avanti has a reported axial resolution of 
5μm and a transverse resolution of 15μm(25). A second commercial OCT-A system used was the 
ZEISS Angioplex (Carl Zeiss Meditec, Dublin, CA) which also uses an 840 nm spectral domain 
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source and has an A-scan rate of 68 kHz. The reported axial and transverse resolution is 5 µm and 
15 µm respectively(26). 
 
Imaging protocols 
Standard imaging procedures differed among the three OCT-A systems. For the prototype OCT-A 
system, three repeat acquisitions at each B-scan location were acquired over a 2x2mm area centered 
on the Foveal Avascular Zone (FAZ) sampled in a 300×300 (×3) grid, which required ∼3.15s for 
image acquisition. The real-time speckle variance (sv) OCT processing and display of the OCT-A 
images was performed using our open source software(27,28). For the RTVue-XR Avanti system, 
images were scanned over 3x3mm regions centered on the FAZ with a scan pattern of 2 repeated B-
scans at 304 raster positions, with each B scan consisting of 304 A-scans. Two volumetric scans 
were acquired in this fashion: one horizontally scanned and the other vertically for a total 
acquisition time of ~6s(25). For the Zeiss Angioplex system, the 3 x 3 mm scan protocol was used, 
which consisted of 245 A-scans per B-scan at 245 B-scan positions. Each B-scan was repeated 4 
times for each position(26). A summary of these protocols is shown in Fig 1. 
 
Fig 1. Imaging protocols for the three different OCT-A systems. 
Green lines indicate the fast scanning direction. The number of locations sampled are labelled for each axis where the 
numbers in brackets (x#) indicate the number of repeated B-scans per location. 
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Processing of OCT-A images 
Post-processing of the image data acquired with the 1060nm prototype OCT-A system started with 
automated motion correction. Coarse axial motion artefact was corrected using cross-correlation 
between adjacent frames then translational sub-pixel registration(29) was then performed on each 
set of corresponding B-scans to further eliminate any inter-scan motion artefact. The inner limiting 
membrane (ILM) and posterior boundary of the outer plexiform layer (OPL) were then segmented 
automatically in 3D using an automated graph-cut algorithm(30). Automated segmentations were 
examined and corrected when necessary by a trained researcher using Amira (version 5.1; Visage 
Imaging, San Diego, CA, USA). The OCT-A scans were then summed in the axial direction 
between the segmented layers to produce a projected en face image. The en face images were then 
automatically notch filtered and contrast-adjusted using adaptive histogram equalization.  
Both commercial images were processed with the systems’ built-in image processing 
software. Briefly, for the Optovue system, the split-spectrum amplitude-decorrelation angiography 
(SSADA) method was used for extracting the OCT-A information. The algorithm split the spectrum 
into 11 sub-spectra and detected blood flow by calculating the signal amplitude-decorrelation 
between two consecutive B-scans of the same location. Both horizontally acquired and vertically 
acquired images were registered and averaged. For the Zeiss system, OCT microangiography 
(OMAG) was used as the OCT-A algorithm, which incorporates both the phase and intensity 
information of the B-scans. The inner limiting membrane (ILM) and posterior boundary of the outer 
plexiform layer (OPL) were also used as the segmentation boundaries for both commercial devices 
as well (26).  
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Manual tracing methods 
One masked, trained rater (FC) segmented all OCT-A images using a Samsung ATIV 
Smart PC Pro 700T tablet (FC) and GNU Image Manipulation Program (GIMP). The segmentations 
were reviewed and accepted by two other trained raters (MH and ZM). 
 
Algorithm training methods   
The automated segmentation of the blood vessels in the OCT-A images was performed by 
classifying each pixel into vessel or non-vessel class using deep convolutional neural networks. A 
detailed description of the DNN architecture has been previously published(19). Briefly, original 
OCT-A en face images and the corresponding manual segmentations were used as inputs to train 
the deep neural network. An equal number of vessel and non-vessel pixels were extracted from each 
image to create a balanced training set. The trained network then segmented the test datasets by 
assigning a grayscale value, with higher values representing higher confidence of the pixel being a 
vessel. The prototype and commercial devices were trained separately due to inherent differences in 
the original images such as the image size. All datasets were trained on a mixed training set 
comprised of both healthy and diabetic images. The first half of the dataset was used to train the 
deep neural network, which was then used to segment the second half of the dataset. The process 
was repeated with the datasets reversed. Due to an icon in the bottom left corner of some data, a 
mask was applied over the area and it was disregarded in further analysis.  
 
Segmentation performance analysis 
The automated deep learning segmentation was thresholded using Otsu’s method to create a binary 
output(31). Segmentation performance was then evaluated by pixel-wise comparison against the 
manually segmented images. The accuracy, sensitivity, and specificity were calculated for each 
pixel in the dataset and presented as a mean average. For each dataset the number of true positive 
(TP), true negative (TN), false positive (FP), and false negative (FN) pixels were used to calculate 
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the accuracy ((TP+TN)/(TP+FP+FN+TN)), sensitivity ((TP/(TP+FN)), and specificity 
(TN/(TN+FP)).  
 
Clinical outcome measures 
Four FAZ morphometric parameters (area, maximum and minimum diameter, and eccentricity) as 
well as perifoveal vessel density were calculated from the automated segmentation results. The FAZ 
was found as the largest connected non-vessel area. The centroid for this area was then used to 
determine the maximum and minimum diameter. Eccentricity was calculated as 𝑒 = √1 −
𝑏2
𝑎2
   
where 𝑏 is the minimum radius and 𝑎 is the maximum radius of the ellipse made by the maximum 
and minimum diameter. Before capillary density measurements were calculated for the automated 
segmentations a gamma correction filter was applied to ensure vessel connectivity after 
binarization. Additionally, all erroneously segmented pixels within the FAZ area were set to a non-
vessel classification. Perifoveal vessel density was then calculated as the proportion of measured 
area occupied by pixels which were classified by the algorithm as a vessel. 
Paired t-tests and Intraclass Correlation Coefficients (ICC) were used to compare the means 
and agreement between segmentation methods, respectively, of the four FAZ morphometric 
parameters and perifoveal vessel density. A Student’s t-test assuming heteroscedasticity was used to 
compare automatically segmented eyes with and without DR. Results for the prototype and 
commercial OCT-A systems were assessed separately. 
 
Results 
Demographics 
A total of 81 eyes from 46 subjects were imaged as per the study protocol. Both eyes were imaged 
for all subjects imaged with the prototype and Optovue system. Three eyes were excluded from 
both the control and diabetic groups of the prototype system due to excessive motion artefacts (5 or 
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more per image). Only one eye (chosen randomly) was imaged per subject with the ZEISS 
Angioplex system, with the exception of 3 control subjects and 2 diabetic subjects. The 
demographics for all study subjects are included in Table 1.  
Table 1. Subject Demographics and Clinical Characteristics 
 
Prototype System Optovue RTVue XR Avanti ZEISS Angioplex  
Subjects (n)    
Control  12 8 10 
Diabetic  5 4 8 
Eyes (n)    
Control 21 16 13 
Diabetic 7 8 10 
ETDRS Grade (n)    
Mild NPDR 1 1 3 
Moderate NPDR - 2 3 
Severe NPDR 2 - 1 
Early PDR 4 5 1 
Age (mean ± std) 37.3 ± 12.5 39.3 ± 13.3 52.7 ± 17.0 
Gender (M:F) 10:7 6:6 8:9 
 
 
Deep Neural Network algorithm performance  
An example of the automated segmentation output for both the prototype and commercial systems 
is shown in Fig 2 along with the corresponding original image and manual segmentation. For the 
images acquired with the Optovue system, the accuracy (healthy: 0.83, diabetic: 0.87), sensitivity 
(healthy: 0.82, diabetic: 0.86), and specificity (healthy: 0.84, diabetic: 0.88) of the deep learning 
algorithm were calculated. The Zeiss system’s accuracy (healthy: 0.84, diabetic: 0.85), sensitivity 
(healthy: 0.84, diabetic: 0.87), and specificity (healthy: 0.83, diabetic: 0.81) were similar. The fields 
of view for the 1060nm prototype system was 2x2mm instead of 3x3mm, but the accuracy (healthy: 
0.797, diabetic: 0.833), sensitivity (healthy: 0.806, diabetic: 0.733), and specificity (healthy: 0.790, 
diabetic: 0.881) were still similar. Although the algorithm performed quite well on most of the 
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images, common OCT-A image quality issues such as low signal-to-noise ratio within the FAZ and 
motion artefacts, as seen in Fig 3, caused erroneous segmentations in some cases.  
 
Fig 2. Sample automated segmentations of OCT-A images from control eyes using a deep neural network. 
As some data within the Optovue RTVue XR Avanti dataset contained an icon in the lower left corner, a mask was 
applied and can be seen in the lower left corner of the automated segmentation results (white). 
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Fig 3. Sample images showing the effects of low quality input data on the automated segmentation. 
Due to the low signal-to-noise ratio within the FAZ, some areas (for example the area within the red box) were 
erroneously segmented. Additionally, a horizontal motion artefact can be seen cutting through the FAZ which was also 
incorrectly segmented in areas (yellow arrows). 
 
Clinical outcome measures 
Representative control images from all systems using both segmentation methods for the FAZ 
perimeter, minimum diameter, and maximum diameter are shown in Fig 4. Table 2 shows the 
results for the clinical outcome measures in both systems. No significant difference existed between 
the means of the clinical parameters derived from the manual and automated segmentations of 
images from the OCT-A systems. All statistical measures are reported in Table 2.  
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Fig 4. Example segmentations and FAZ parameterization of control eyes for all three systems in the study. FAZ 
parameters such as FAZ perimeter (yellow), maximum diameter (green) and minimum diameter (red) are shown for 
example healthy from 3 OCT-A systems using both manually and automated segmentations. As some data within the 
Optovue RTVue XR Avanti dataset contained an icon in the lower left corner, a mask was applied and can be seen in the 
lower left corner of the automated segmentation results (white). 
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Table 2. Clinical Outcomes Measures for Comparing Automated and Manual Vessel 
Segmentation 
 
  
FAZ Area 
(mm2) 
Minimum 
FAZ Diameter 
(mm) 
Maximum 
FAZ Diameter 
(mm)  
FAZ 
Eccentricity 
Perifoveal vessel 
Density 
(%) 
Z
ei
ss
 O
C
T
-A
 
Healthy (n = 13) 
Manual 0.278 ± 0.130 0.478 ± 0.116 0.736 ± 0.214 0.750 ± 0.052 0.493 ± 0.026 
Automated 0.332 ± 0.154 0.500 ± 0.102 0.748 ± 0.172 0.730 ± 0.064 0.513 ± 0.034 
T-test p = 0.35 p = 0.60 p = 0.90 p = 0.41 p = 0.11 
ICC 0.96 0.97 0.96 0.51 0.94 
Diabetic (n = 10) 
Manual 0.552 ± 0.416 0.539 ± 0.217 1.035 ± 0.436 0.837 ± 0.056 0.378 ± 0.069 
Automated 0.736 ± 0.480 0.514 ± 0.166 1.164 ± 0.354 0.886 ± 0.047 0.418 ± 0.058 
T-test p = 0.37 p = 0.78 p = 0.48 p = 0.06 p = 0.18 
ICC 0.93 0.96 0.90 0.74 0.88 
O
p
to
v
u
e 
O
C
T
-A
 
Healthy (n = 16) 
Manual 0.280 ± 0.098 0.514 ± 0.114 0.704 ± 0.123 0.677 ± 0.087 0.519 ± 0.042 
Automated 0.261 ± 0.080 0.472 ± 0.096 0.689 ± 0.123 0.717 ± 0.089 0.525 ± 0.014 
T-test p = 0.69 p = 0.27 p = 0.86 p = 0.16 p = 0.42 
ICC 0.94 0.99 0.89 0.85 0.54 
Diabetic (n = 8) 
Manual 0.594 ± 0.347 0.634 ± 0.226 1.114 ± 0.363 0.792 ± 0.097 0.385 ± 0.053 
Automated 0.492 ± 0.249 0.537 ± 0.159 0.950 ± 0.273 0.810 ± 0.089 0.418 ± 0.048 
T-test p = 0.51 p = 0.34 p = 0.32 p = 0.70 p = 0.25 
ICC 0.97 0.96 0.92 0.90 0.98 
P
ro
to
ty
p
e 
O
C
T
-A
 
Healthy (n = 21) 
Manual 0.300 ± 0.146 0.485 ± 0.174 0.707 ± 0.229 0.721 ± 0.083 0.381 ± 0.043 
Automated 0.279 ± 0.113 0.470 ± 0.130 0.707 ± 0.159 0.740 ± 0.092 0.388 ± 0.015 
T-test p = 0.11 p = 0.58 p = 0.97 p = 0.34 p = 0.54 
ICC 0.96 0.89 0.87 0.85 0.68 
Diabetic (n = 7) 
Manual 0.415±0.164 0.516 ± 0.161 0.928 ± 0.164 0.819 ± 0.083 0.311±0.047 
Automated 0.366±0.104 0.446 ± 0.088 0.895 ± 0.172 0.852 ± 0.052 0.281±0.015 
T-test p=0.23 p=0.13 p=0.52 p=0.30 p=0.09 
ICC 0.89 0.83 0.86 0.62 0.63 
The mean (± STD) of the clinical outcome parameters (FAZ area, minimum diameter, maximum 
diameter, eccentricity and perifoveal vessel density) are shown for both healthy and diabetic eyes 
and both OCT-A systems. The p-value from the paired t-test and the Intraclass Correlation 
Coefficient (ICC) value is also shown to compare manual and automated methods. 
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For all three OCT-A systems, eyes with DR had significantly lower perifoveal vessel density, 
greater maximum diameter, and greater FAZ eccentricity compared to the healthy eyes (p<0.05). 
Eyes with DR and normal eyes did not have any statistically significant differences in the FAZ area 
or minimum diameter in any system. Representative diabetic images from all systems using both 
segmentation methods for the FAZ perimeter, minimum diameter, and maximum diameter are 
shown in Fig 5. 
 
Fig 5. Diabetic eyes have larger maximum diameter and eccentricity. FAZ parameters such as FAZ perimeter 
(yellow), maximum diameter (green) and minimum diameter (red) are shown for example diabetic data from 3 OCT-A 
systems using both manually and automated segmentations. As the data within the Optovue RTVue XR Avanti dataset 
contained an icon in the lower left corner, a mask was applied and can be seen in the lower left corner of the manual 
segmentation (black) and automated segmentation results (white). 
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Discussion 
This study demonstrates the ability of a machine-learning based automated segmentation algorithm 
to segment the vessels of both healthy and diabetic eyes imaged with prototype and commercial 
OCT-A devices. The major findings of the study are: 1) Pixel-wise, the accuracy of the automated 
segmentation was comparable to that of a manual rater in all three OCT-A platforms, 2) Deep 
learning based segmentation can reliably quantify the perifoveal vessel density compared to manual 
segmentation across multiple OCT-A platforms and 3) Deep learning based segmentation has the 
capacity to reliably quantify the FAZ area, eccentricity, maximum and minimum diameter 
compared to manual raters across OCT-A platforms. 
The fovea centralis is the anatomical area responsible for the highest visual acuity. With the 
exception of the foveola, the metabolic demands of the fovea centralis are met by a unique 
arrangement of superficial retinal capillaries(32). These end-arterial capillaries lack anastomoses 
which make this retinal eccentricity especially vulnerable to ischemic insult by retinal vascular 
diseases, including DR(33). Perifoveal vessel ischemia and FAZ enlargement are well-documented 
observations of macular ischemia in DR and are correlated to disease severity and progression(6–8). 
While FA remains the current clinical standard for evaluating macular ischemia, its invasive nature 
and potential adverse events makes it challenging to incorporate in regular screening and frequent 
follow-up of patients with DR. OCT-A is an alternative non-invasive, label-free imaging modality 
that has been favorably compared to histological representation and FA in the visualization of 
perifoveal circulation in healthy subjects and patients with DR. Accurate methods of quantification 
and analysis of OCT-A images are of great research and clinical interest. Optovue’s built-in 
automated vessel segmentation extrapolates skeletonized outputs to show vessel density maps 
(34,35). Potential limitations to this method include underestimating vessel density in areas with 
thicker vessels and decreased sensitivity to capillary dropout(36). A more recently published 
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approach by Schottenhamml et al.(36) takes advantage of a ‘vesselness’ filter to exploit the 
interconnective nature of the retinal vasculature and generate more detailed vessel segmentations; 
however, inaccuracies seem to result with vessel shape at vertices. The deep learning based method 
used in this report takes advantage of the 2-dimensional spatial structure of training images and was 
able to accurately mimic manual segmentations. Pixel-wise, the accuracy of the automated 
segmentation outputs compared to manual ranged from 76-91%, which is comparable to a reported 
inter-rater manual segmentation of ~83% agreement(19). 
Perifoveal vessel non-perfusion is defined as the pathological disruption of perifoveal 
circulation with subsequent enlargement of inter-vessel distances between perifoveal vessel 
networks(7). It has been suggested that early perifoveal vessel non-perfusion could be present and 
represent an important biomarker in the absence of obvious DR on clinical examination(37) OCT-A 
has been shown to be able to delineate the perifoveal vessel networks precisely and consistently in 
patients with DR(38). This serves as a motivation to develop an automated tool that can accurately 
and reliably quantify the perifoveal vessel density. We found no statistically significant difference 
in the means of the perifoveal vessel densities when comparing measurements derived from the 
automated and manual segmentations. In comparing diabetic and healthy eyes, the automated 
outputs from both systems found a significantly lower (p<0.01) perifoveal vessel density in the DR 
eyes. This suggests that perifoveal vessel density calculated using deep learning based segmentation 
might be a clinically useful tool in the evaluation and follow-up of ischemic changes in DR.  
The FAZ approximately delineates the location of the foveola within the fovea centralis.  
The absence of retinal vasculature is believed to help optimize the image on central cones(39). 
Increased FAZ area has been well-correlated with decreased visual acuity(8) and the severity of 
capillary nonperfusion(5,7) in patients with DR. Although there is high inter-individual variability 
in FAZ metrics for healthy eyes, longitudinal progression of the FAZ morphology may be a useful 
biomarker for DR(21). Improved visualization of the FAZ, enabled by OCT-A has allowed 
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researchers to further study this area as it relates to DR(40), retinal vein occlusion(41), and 
aging(34). To assess the clinical utility of the automated segmentations in calculating FAZ 
morphometric parameters, the FAZ area, minimum and maximum diameter, and eccentricity were 
calculated using both the manual and automated segmentations. No significant difference existed 
between the means of any morphometric parameters derived from the manual and automated 
segmentations. For all three systems, the diabetic eyes were found to have a greater FAZ maximum 
diameter, and greater eccentricity compared to the healthy eyes while no significant difference in 
FAZ area or minimum diameter was noted. This lack of correlation is likely due to the high inter-
individual variability. A non-circular FAZ shape has been shown to be a sensitive marker for early 
DR (42,43) and may be a more reliable biomarker as indicated by the greater eccentricity in DR 
eyes.  
This study demonstrates the ability of a deep learning based automated segmentation 
algorithm to reliably segment the perifoveal microvasculature and provide clinically useful FAZ 
morphological measures. A limitation of this study is a restricted sample size for the diabetic 
groups. Additionally, as the performance of a deep learning based approach is limited by the quality 
of the training data, our automated segmentation performance is limited by image quality and 
manual vessel segmentations. Although the manual segmentations were reviewed by two trained 
raters in an attempt to mitigate manual segmentation error, the segmentations were reviewed on a 
holistic level whereas the machine learns on a pixel-by-pixel basis. Another limitation is the need 
for a database of segmented images for each field of view and each machine. Most commercial 
machines allow the imaging of various different fields of view (for example 3x3, 6x6, and 8x8mm), 
of which we only chose to use 2x2mm and 3x3mm to analyze in this study. Experimentally, 
performance variability in the vessel thickness occurred when the training set and the segmented 
images were from different fields of view, therefore a training set is needed for each field of view.    
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Systematic screening of people with diabetes has been shown to be a cost-effective 
approach for identifying potential vision loss(44). OCT-A is a promising new technology that has 
the potential to help guide earlier management decisions and prognosis. Deep learning automated 
segmentation of OCT-A may be suitable for both commercial and research purposes for better 
quantification of the retinal circulation in healthy subjects and in subjects with retinal vascular 
disease. 
 
Acknowledgements 
The authors would like to thank the following agencies for funding: Michael Smith Foundation for 
Health Research, Natural Sciences and Engineering Research Council of Canada, Canadian 
Institutes of Health Research and National Health, and Brain Canada. 
 
References 
1.  Yau JWY, Rogers SL, Kawasaki R, Lamoureux EL, Kowalski JW, Bek T, et al. Global 
prevalence and major risk factors of diabetic retinopathy. Diabetes Care. 2012;35(3):556–64.  
2.  Flaxman SR, Bourne RRA, Resnikoff S, Ackland P, Braithwaite T, Cicinelli M V, et al. 
Global causes of blindness and distance vision impairment 1990-2020: a systematic review 
and meta-analysis. Lancet Glob Heal. 2017 Dec;5(12):e1221–34.  
3.  Nentwich MM, Ulbig MW. Diabetic retinopathy - ocular complications of diabetes mellitus. 
World J Diabetes. 2015;6(3):489–99.  
4.  Antonetti DA, Klein R, Gardner TW. Diabetic Retinopathy. N Engl J Med. 2012;366:1227–
39.  
5.  Bresnick G, De Venecia G, Myers F, Harris J, Davis M. Retinal ischemia in diabetic 
retinopathy. Arch Ophthalmol. 1975;93(12):1300–10.  
6.  Lutty GA. Effects of diabetes on the eye. Investig Ophthalmol Vis Sci. 2013;54(14).  
7.  Arend O, Wolf S, Harris A, Reim M. The Relationship of Macular Microcirculation to 
Visual-Acuity in Diabetic-Patients. Arch Ophthalmol. 1995;113(5):610–4.  
8.  Balaratnasingam C, Inoue M, Ahn S, McCann J, Dhrami-Gavazi E, Yannuzzi LA, et al. 
Visual Acuity Is Correlated with the Area of the Foveal Avascular Zone in Diabetic 
Retinopathy and Retinal Vein Occlusion. Ophthalmology. 2016;  
9.  Mendis KR, Balaratnasingam C, Yu P, Barry CJ, McAllister IL, Cringle SJ, et al. 
Correlation of histologic and clinical images to determine the diagnostic value of fluorescein 
angiography for studying retinal capillary detail. Invest Ophthalmol Vis Sci. 2010 
Nov;51(11):5864–9.  
10.  Weinhaus RS, Burke JM, Delori FC, Snodderly DM. Comparison of fluorescein 
angiography with microvascular anatomy of macaque retinas. Exp Eye Res. 1995 
Jul;61(1):1–16.  
11.  Yu PK, Balaratnasingam C, Xu J, Morgan WH, Mammo Z, Han S, et al. Label-Free Density 
20 
 
Measurements of Radial Peripapillary Capillaries in the Human Retina. PLoS One. 
2015;10(8):e0135151.  
12.  Tan PEZ, Balaratnasingam C, Xu J, Mammo Z, Han SX, Mackenzie P, et al. Quantitative 
Comparison of Retinal Capillary Images Derived By Speckle Variance Optical Coherence 
Tomography With Histology. Investig Ophthalmol Vis Sci. 2015;56(6):3989–96.  
13.  Chan G, Balaratnasingam C, Xu J, Mammo Z, Han S, Mackenzie P, et al. In vivo optical 
imaging of human retinal capillary networks using speckle variance optical coherence 
tomography with quantitative clinico-histological correlation. Microvasc Res. 2015;100:32–
9.  
14.  Mammo Z, Balaratnasingam C, Yu P, Xu J, Heisler M, Mackenzie P, et al. Quantitative 
Noninvasive Angiography of the Fovea Centralis Using Speckle Variance Optical 
Coherence TomographySpeckle Variance Optical Coherence Tomography of Macula. 
Investig Ophthalmol Vis Sci. 2015;56(9):5074–86.  
15.  Inoue M, Jung JJ, Balaratnasingam C, Dansingani KK, Dhrami-Gavazi E, Suzuki M, et al. A 
Comparison Between Optical Coherence Tomography Angiography and Fluorescein 
Angiography for the Imaging of Type 1 Neovascularization. Invest Ophthalmol Vis Sci. 
2016 Jul;57(9):OCT314-23.  
16.  Kim DY, Fingler J, Zawadzki RJ, Park SS, Morse LS, Schwartz DM, et al. Noninvasive 
imaging of the foveal avascular zone with high-speed, phase-variance optical coherence 
tomography. Investig Ophthalmol Vis Sci. 2012;53(1):85–92.  
17.  Gadde SGK, Anegondi N, Bhanushali D, Chidambara L, Yadav NK, Khurana A, et al. 
Quantification of vessel density in retinal optical coherence tomography angiography images 
using local fractal dimension. Investig Ophthalmol Vis Sci. 2016;57(1):246–52.  
18.  de Carlo TE, Romano A, Waheed NK, Duker JS. A review of optical coherence tomography 
angiography (OCTA). Int J Retin Vitr. 2015;1(1):5.  
19.  Prentasic P, Heisler M, Lee S, Mammo Z, Merkur AB, Navajas E, et al. Segmentation of the 
Foveal Microvasculature Using Deep Learning Networks. J Biomed Opt. 2016 
Jul;21(7):75008.  
20.  Spaide RF, Curcio CA. Evaluation of Segmentation of the Superficial and Deep Vascular 
Layers of the Retina by Optical Coherence Tomography Angiography Instruments in 
Normal Eyes. JAMA Ophthalmol. 2017;135(3):259–62.  
21.  Hwang TS, Gao SS, Liu L, Lauer AK, Bailey ST, Flaxel CJ, et al. Automated quantification 
of capillary nonperfusion using optical coherence tomography angiography in diabetic 
retinopathy. JAMA Ophthalmol. 2016;134(4):367–73.  
22.  Jia Y, Morrison JC, Tokayer J, Tan O, Lombardi L, Baumann B, et al. Quantitative OCT 
angiography of optic nerve head blood flow. Biomed Opt Express. 2012 Dec;3(12):3127–37.  
23.  Early Treatment Diabetic Retinopathy Study Research Group. Fluorescein angiographic risk 
factors for progression of diabetic retinopathy. ETDRS report number 13. Early Treatment 
Diabetic Retinopathy Study Research Group. Ophthalmology. 1991;98(5 Suppl):834–40.  
24.  Xu J, Han S, Balaratnasingam C, Mammo Z, Wong KSK, Lee S, et al. Retinal angiography 
with real-time speckle variance optical coherence tomography. Br J Ophthalmol. 2015;1–5.  
25.  Optovue Incorporated. AngioVue Imaging System Brochure. Fremont, CA; 2015. 1-12 p.  
26.  Rosenfeld PJ, Durbin MK, Roisman L, Zheng F, Miller A, Robbins G, et al. ZEISS 
AngioplexTM Spectral Domain Optical Coherence Tomography Angiography: Technical 
Aspects. Dev Ophthalmol. 2016;56:18–29.  
27.  Xu J, Wong K, Jian Y, Sarunic M V. Real-time acquisition and display of flow contrast 
using speckle variance optical coherence tomography in a graphics processing unit. J 
Biomed Opt. 2014;19(2):26001.  
28.  Jian Y, Wong K, Sarunic M V. Graphics processing unit accelerated optical coherence 
21 
 
tomography processing at megahertz axial scan rate and high resolution video rate 
volumetric rendering. J Biomed Opt. 2013;18(2):26002.  
29.  Guizar-Sicairos M, Thurman ST, Fienup JR. Efficient subpixel image registration 
algorithms. Opt Lett. 2008;33(2):156–8.  
30.  Lee S, Fallah N, Forooghian F, Ko A, Pakzad-Vaezi K, Merkur AB, et al. Comparative 
analysis of repeatability of manual and automated choroidal thickness measurements in 
nonneovascular age-related macular degeneration. Investig Ophthalmol Vis Sci. 
2013;54(4):2864–71.  
31.  Otsu N. A threshold selection method from gray-level histograms. IEEE Trans Syst Man 
Cybern. 1979;9(1):62–6.  
32.  Yu DY, Cringle SJ. Oxygen distribution and consumption within the retina in vascularised 
and avascular retinas and in animal models of retinal disease. Vol. 20, Progress in Retinal 
and Eye Research. 2001. p. 175–208.  
33.  Bek T. Inner retinal ischaemia: current understanding and needs for further investigations. 
Acta Ophthalmol. 2009 Jun;87(4):362–7.  
34.  Iafe NA, Phasukkijwatana N, Chen X, Sarraf D. Retinal Capillary Density and Foveal 
Avascular Zone Area Are Age-Dependent: Quantitative Analysis Using Optical Coherence 
Tomography AngiographyQuantitative Analysis Using OCT Angiography. Invest 
Ophthalmol Vis Sci. 2016;57(13):5780.  
35.  Agemy S a., Scripsema NK, Shah CM, Chui T, Garcia PM, Lee JG, et al. RETINAL 
VASCULAR PERFUSION DENSITY MAPPING USING OPTICAL COHERENCE 
TOMOGRAPHY ANGIOGRAPHY IN NORMALS AND DIABETIC RETINOPATHY 
PATIENTS. Retina. 2015 Nov;35(11):2353–63.  
36.  Schottenhamml J, Moult EM, Ploner S, Lee B, Novais EA, Cole E, et al. AN AUTOMATIC, 
INTERCAPILLARY AREA-BASED ALGORITHM FOR QUANTIFYING DIABETES-
RELATED CAPILLARY DROPOUT USING OPTICAL COHERENCE TOMOGRAPHY 
ANGIOGRAPHY. Retina. 2016;  
37.  Nagaoka T, Sato E, Takahashi A, Yokota H, Sogawa K, Yoshida A. Impaired retinal 
circulation in patients with type 2 diabetes mellitus: retinal laser Doppler velocimetry study. 
Invest Ophthalmol Vis Sci. 2010 Dec;51(12):6729–34.  
38.  DA S, de Carlo TE, M A, et al. Select features of diabetic retinopathy on swept-source 
optical coherence tomographic angiography compared with fluorescein angiography and 
normal eyes. JAMA Ophthalmol. 2016;134(6):644–50.  
39.  Provis JM, Dubis AM, Maddess T, Carroll J. Adaptation of the central retina for high acuity 
vision: cones, the fovea and the avascular zone. Prog Retin Eye Res. 2013 Jul;35:63–81.  
40.  Al-Sheikh M, Akil H, Pfau M, Sadda SR. Swept-Source OCT Angiography Imaging of the 
Foveal Avascular Zone and Macular Capillary Network Density in Diabetic 
RetinopathyOCT-Angiography in Diabetic Retinopathy. Invest Ophthalmol Vis Sci. 
2016;57(8):3907.  
41.  Kang J-W, Yoo R, Jo YH, Kim HC. CORRELATION OF MICROVASCULAR 
STRUCTURES ON OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY WITH 
VISUAL ACUITY IN RETINAL VEIN OCCLUSION. RETINA. 9000 Nov;Publish Ah.  
42.  Krawitz BD, Mo S, Geyman LS, Agemy SA, Scripsema NK, Garcia PM, et al. Acircularity 
index and axis ratio of the foveal avascular zone in diabetic eyes and healthy controls 
measured by optical coherence tomography angiography. Vision Res. 2017 Feb;  
43.  Bresnick GH, Condit R, Syrjala S, Palta M, Groo A, Korth K. Abnormalities of the foveal 
avascular zone in diabetic retinopathy. Arch Ophthalmol. 1984;102(9):1286–93.  
44.  Philip S, Fleming AD, Goatman KA, Fonseca S, Mcnamee P, Scotland GS, et al. The 
efficacy of automated “disease/no disease” grading for diabetic retinopathy in a systematic 
22 
 
screening programme. Br J Ophthalmol. 2007 Nov 15;91(11):1512–7.  
 
